Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2023)

Historic Interest Coverage Ratio for Vivos Therapeutics (VVOS) over the last 4 years, with Q4 2023 value amounting to 2.3.

  • Vivos Therapeutics' Interest Coverage Ratio fell 1361.26% to 2.3 in Q4 2023 from the same period last year, while for Dec 2023 it was 9.61, marking a year-over-year decrease of 1496.43%. This contributed to the annual value of 9.61 for FY2023, which is 1516.39% down from last year.
  • As of Q4 2023, Vivos Therapeutics' Interest Coverage Ratio stood at 2.3, which was down 1361.26% from 2.02 recorded in Q4 2022.
  • Vivos Therapeutics' 5-year Interest Coverage Ratio high stood at 2.02 for Q4 2022, and its period low was 4061.0 during Q2 2021.
  • Its 4-year average for Interest Coverage Ratio is 850.41, with a median of 174.71 in 2022.
  • As far as peak fluctuations go, Vivos Therapeutics' Interest Coverage Ratio tumbled by 572238.5% in 2021, and later skyrocketed by 9989.09% in 2022.
  • Vivos Therapeutics' Interest Coverage Ratio (Quarter) stood at 362.86 in 2020, then plummeted by 410.6% to 1852.75 in 2021, then skyrocketed by 99.89% to 2.02 in 2022, then dropped by 13.61% to 2.3 in 2023.
  • Its last three reported values are 2.3 in Q4 2023, 2.02 for Q4 2022, and 150.19 during Q3 2022.